Is Hong Kong PGT-M for Monogenic Disease Screening Reliable? Technical Principles, Accuracy, Regulatory Process
Hong Kong PGT-M for monogenic disease screening ranks among the top internationally in technical reliability and regulatory maturity. Using NGS or SNP chip technology, accuracy is 95%-99%, with a 0.1%-0.5% misdiagnosis rate. This article analyzes technical principles, regulatory systems, process timelines, risk details, and applicable scenarios to help couples carrying known pathogenic gene mutations make informed decisions.